OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Research progress on the anti-hepatic fibrosis action and mechanism of natural products
Liang Shan, Zhenni Liu, Leilei Ci, et al.
International Immunopharmacology (2019) Vol. 75, pp. 105765-105765
Closed Access | Times Cited: 89
Liang Shan, Zhenni Liu, Leilei Ci, et al.
International Immunopharmacology (2019) Vol. 75, pp. 105765-105765
Closed Access | Times Cited: 89
Showing 1-25 of 89 citing articles:
Molecular Mechanisms and Potential New Therapeutic Drugs for Liver Fibrosis
Fa-Da Wang, Jing Zhou, En‐Qiang Chen
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 50
Fa-Da Wang, Jing Zhou, En‐Qiang Chen
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 50
Selenomethionine Attenuates Aflatoxin B1-induced Liver Injury by Modulating the Gut Microbiota and Metabolites in Rabbits
Dejing Kong, Jingyi Xu, Qianwen Zhang, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access | Times Cited: 1
Dejing Kong, Jingyi Xu, Qianwen Zhang, et al.
Journal of Agricultural and Food Chemistry (2025)
Closed Access | Times Cited: 1
TIM‐4 interference in Kupffer cells against CCL4‐induced liver fibrosis by mediating Akt1/Mitophagy signalling pathway
Hao Wu, Guoyong Chen, Jingyuan Wang, et al.
Cell Proliferation (2019) Vol. 53, Iss. 1
Open Access | Times Cited: 67
Hao Wu, Guoyong Chen, Jingyuan Wang, et al.
Cell Proliferation (2019) Vol. 53, Iss. 1
Open Access | Times Cited: 67
Curcumol alleviates liver fibrosis through inducing autophagy and ferroptosis in hepatic stellate cells
Yang Zheng, Tiejian Zhao, Jiaru Wang, et al.
The FASEB Journal (2022) Vol. 36, Iss. 12
Closed Access | Times Cited: 34
Yang Zheng, Tiejian Zhao, Jiaru Wang, et al.
The FASEB Journal (2022) Vol. 36, Iss. 12
Closed Access | Times Cited: 34
18beta-glycyrrhetinic acid induces ROS-mediated apoptosis to ameliorate hepatic fibrosis by targeting PRDX1/2 in activated HSCs
Qian Zhang, Piao Luo, Liuhai Zheng, et al.
Journal of Pharmaceutical Analysis (2022) Vol. 12, Iss. 4, pp. 570-582
Open Access | Times Cited: 32
Qian Zhang, Piao Luo, Liuhai Zheng, et al.
Journal of Pharmaceutical Analysis (2022) Vol. 12, Iss. 4, pp. 570-582
Open Access | Times Cited: 32
Current advances and potential trends of the polysaccharides derived from medicinal mushrooms sanghuang
Hao Wang, Jin-Xin Ma, Miao Zhou, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 32
Hao Wang, Jin-Xin Ma, Miao Zhou, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 32
The potential of therapeutic strategies targeting mitochondrial biogenesis for the treatment of insulin resistance and type 2 diabetes mellitus
Wenwen Ding, Xiaoxue Yang, Kaiyi Lai, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 3, pp. 219-248
Closed Access | Times Cited: 6
Wenwen Ding, Xiaoxue Yang, Kaiyi Lai, et al.
Archives of Pharmacal Research (2024) Vol. 47, Iss. 3, pp. 219-248
Closed Access | Times Cited: 6
Forsythiaside A Regulates Activation of Hepatic Stellate Cells by Inhibiting NOX4-Dependent ROS
Mengting Zhou, Xingtao Zhao, Li Liao, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 27
Mengting Zhou, Xingtao Zhao, Li Liao, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-17
Open Access | Times Cited: 27
Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy
Liyue Zhou, Qiangwei Liang, Yifan Li, et al.
Acta Biomaterialia (2022) Vol. 152, pp. 235-254
Closed Access | Times Cited: 25
Liyue Zhou, Qiangwei Liang, Yifan Li, et al.
Acta Biomaterialia (2022) Vol. 152, pp. 235-254
Closed Access | Times Cited: 25
From liver fibrosis to hepatocarcinogenesis: Role of excessive liver H2O2 and targeting nanotherapeutics
Meiyu Shao, Yifan Wang, Hongyan Dong, et al.
Bioactive Materials (2022) Vol. 23, pp. 187-205
Open Access | Times Cited: 23
Meiyu Shao, Yifan Wang, Hongyan Dong, et al.
Bioactive Materials (2022) Vol. 23, pp. 187-205
Open Access | Times Cited: 23
USP9X-mediated NRP1 deubiquitination promotes liver fibrosis by activating hepatic stellate cells
Jinqiu Zhao, Jie Bai, Fengling Peng, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Jinqiu Zhao, Jie Bai, Fengling Peng, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
An Autologous Macrophage‐Based Phenotypic Transformation‐Collagen Degradation System Treating Advanced Liver Fibrosis
Bo‐Wen Duan, Yanjun Liu, Xue‐Na Li, et al.
Advanced Science (2023) Vol. 11, Iss. 7
Open Access | Times Cited: 14
Bo‐Wen Duan, Yanjun Liu, Xue‐Na Li, et al.
Advanced Science (2023) Vol. 11, Iss. 7
Open Access | Times Cited: 14
Decoding active compounds and molecular targets of herbal medicine by high-throughput metabolomics technology: A systematic review
Zhibo Wang, Sifan Guo, Ying Cai, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107090-107090
Closed Access | Times Cited: 6
Zhibo Wang, Sifan Guo, Ying Cai, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107090-107090
Closed Access | Times Cited: 6
Co-catalpol alleviates fluoxetine-induced main toxicity: Involvement of ATF3/FSP1 signaling-mediated inhibition of ferroptosis
Xiaohui Wu, Yuechen Guan, Junming Wang, et al.
Phytomedicine (2024) Vol. 126, pp. 155340-155340
Closed Access | Times Cited: 6
Xiaohui Wu, Yuechen Guan, Junming Wang, et al.
Phytomedicine (2024) Vol. 126, pp. 155340-155340
Closed Access | Times Cited: 6
Artificial Intelligence in Liver Diseases: Recent Advances
Feifei Lu, Meng Yao, Xiaoting Song, et al.
Advances in Therapy (2024) Vol. 41, Iss. 3, pp. 967-990
Closed Access | Times Cited: 5
Feifei Lu, Meng Yao, Xiaoting Song, et al.
Advances in Therapy (2024) Vol. 41, Iss. 3, pp. 967-990
Closed Access | Times Cited: 5
Flavonoids-based nanomedicines for the treatment of liver fibrosis: A recent progress
Karthik Shree Harini, Devaraj Ezhilarasan
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105467-105467
Closed Access | Times Cited: 5
Karthik Shree Harini, Devaraj Ezhilarasan
Journal of Drug Delivery Science and Technology (2024) Vol. 93, pp. 105467-105467
Closed Access | Times Cited: 5
The study on in vitro antioxidant properties, cellular immune activities and mice anti-fatigue effects of Sanghuangporus vanninii mycelium polysaccharides
L. L. Zhang, Qian Wang, Nengbin Gao, et al.
Food Bioscience (2024) Vol. 61, pp. 104640-104640
Closed Access | Times Cited: 5
L. L. Zhang, Qian Wang, Nengbin Gao, et al.
Food Bioscience (2024) Vol. 61, pp. 104640-104640
Closed Access | Times Cited: 5
Hepatoprotective Effect and Potential Mechanism of Aqueous Extract from Phyllanthus emblica on Carbon-Tetrachloride-Induced Liver Fibrosis in Rats
Kehuan Yin, Xuedong Li, Xiaomin Luo, et al.
Evidence-based Complementary and Alternative Medicine (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 28
Kehuan Yin, Xuedong Li, Xiaomin Luo, et al.
Evidence-based Complementary and Alternative Medicine (2021) Vol. 2021, pp. 1-12
Open Access | Times Cited: 28
Pathogenesis of Liver Fibrosis and Its TCM Therapeutic Perspectives
Yang Nan, HongChan Su, Xiao-Mei Lian, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 20
Yang Nan, HongChan Su, Xiao-Mei Lian, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 20
Traditional Chinese medicine: An important source for discovering candidate agents against hepatic fibrosis
Wenqing Li, Wenhao Liu, Die Qian, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
Wenqing Li, Wenhao Liu, Die Qian, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
Eupatilin Ameliorates Hepatic Fibrosis and Hepatic Stellate Cell Activation by Suppressing β-catenin/PAI-1 Pathway
Jinyuan Hu, Yuanyuan Liu, Zheng Pan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5933-5933
Open Access | Times Cited: 12
Jinyuan Hu, Yuanyuan Liu, Zheng Pan, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5933-5933
Open Access | Times Cited: 12
Natural products target glycolysis in liver disease
Shenghao Li, Liyuan Hao, Xiaoyu Hu
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Shenghao Li, Liyuan Hao, Xiaoyu Hu
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Anti-Fibrotic Efficacy of Apigenin in a Mice Model of Carbon Tetrachloride-Induced Hepatic Fibrosis by Modulation of Oxidative Stress, Inflammation, and Fibrogenesis: A Preclinical Study
Maryam Melaibari, Huda M. Alkreathy, Ahmed Esmat, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1342-1342
Open Access | Times Cited: 11
Maryam Melaibari, Huda M. Alkreathy, Ahmed Esmat, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1342-1342
Open Access | Times Cited: 11
Therapeutic potential and mechanism of Chinese herbal medicines in treating fibrotic liver disease
Yanwei Li, Yunrui LU, Mozuo NIAN, et al.
Chinese Journal of Natural Medicines (2023) Vol. 21, Iss. 9, pp. 643-657
Closed Access | Times Cited: 11
Yanwei Li, Yunrui LU, Mozuo NIAN, et al.
Chinese Journal of Natural Medicines (2023) Vol. 21, Iss. 9, pp. 643-657
Closed Access | Times Cited: 11
Effects of Mesenchymal Stem Cells-Derived Extracellular Vesicles on Inhibition of Hepatic Fibrosis by Delivering miR-200a
Ailei Xu, Long Han, Jun Yan, et al.
Tissue Engineering and Regenerative Medicine (2024) Vol. 21, Iss. 4, pp. 609-624
Closed Access | Times Cited: 4
Ailei Xu, Long Han, Jun Yan, et al.
Tissue Engineering and Regenerative Medicine (2024) Vol. 21, Iss. 4, pp. 609-624
Closed Access | Times Cited: 4
